Arena Pharmaceuticals, Inc.

pfizer.com · San Diego, United States of America

Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule therapeutics for immunology, gastroenterology, and cardiology indications. The company generated revenue primarily through licensing, collaboration agreements, and eventual product commercialization before being acquired by Pfizer, which now integrates Arena’s pipeline into its broader pharmaceutical portfolio.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
1997
Headquarters
San Diego, United States of America

Arena Pharmaceuticals, Inc. customers on Arbolus

Total customers 8 7 current · 1 former
Reviews growth 5 new reviews since Jun 2026

Customers who reviewed Arena Pharmaceuticals, Inc.

Seniority of Arena Pharmaceuticals, Inc. customers

Most people who reviewed Arena Pharmaceuticals, Inc. hold Director roles (88%), followed by C-Suite (12%).

  • Director 88%
  • C-Suite 12%

Customers sample

Operations Manager Director NPS 9 Will renew
Not specified Director NPS 10
Revenue Partner Director NPS 8

Employer names and spend open once the report publishes.

What 5 Arbolus experts think of Arena Pharmaceuticals, Inc.

Overall sentiment: Positive

NPS scores are consistently strong, with 70% scoring 8–10. Renewal intent is positive overall, though there is notable uncertainty among high spenders. Stickiness is high: a majority remain implemented more than 1 year, while a minority are in pilot or early stages. Consistently strong NPS, high adoption duration, and significant spend by Influencers denote stable satisfaction, yet renewal uncertainty among top spenders highlights areas needing monitoring.

Tell us when the Arena Pharmaceuticals, Inc. report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

80 Net Promoter Score, from 5 scored reviews
  • Promoters 4
  • Passives 1
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 60%
  • Will renew 3
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • Director 60% 5 answers
  • 8/10 Average score from customers who will renew
  • 8.5/10 Average score from undecided customers

For people who use Arena Pharmaceuticals, Inc.

Do you use Arena Pharmaceuticals, Inc. at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 5 customers of Arena Pharmaceuticals, Inc. have already contributed

Takes a few minutes. Your identity stays anonymous.